Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call Transcript

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q2 2025 Earnings Call Transcript August 13, 2025

Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-3.75.

Operator: Good morning, and welcome to Mersana Therapeutics Second Quarter 2025 Financial Results and Business Update Conference Call and Webcast. [Operator Instructions] Please note, this call is being recorded. I would now like to turn the call over to Jason Fredette, Senior Vice President,...